Researchers reported no new safety concerns
Ozempic, also known as semaglutide, is a weekly injection that can help to lower blood sugar by causing the pancreas to provide a higher volume of insulin
She explains that flexible tapering strategies are key to successful antidepressant discontinuation in primary care GLP-1 receptor agonists: Optimising nutritional outcomes in primary care GLP-1 receptor agonists: Optimising nutritional outcomes in primary care Dietitian Sarah MacAvoy explains that while new weight-loss medications show exciting potential, they also put patients at risk of nutritional deficiencies, and dietitian support is essential Kia ora and welcome to Pharmacy Today Kaitiaki Rongo O Te W Not a subscriber
Polyethylene glycol, an effective osmotic laxative, has been shown to have potential in improving CHE [147]
This high energy demand creates a byproduct of oxidative stress
The verdict Conditional on most plans Blue Shield of California restricts new Wegovy weight-loss starts to BMI 40 or higher (Class III/morbid obesity) since January 1, 2025 meaning patients at BMI 3039 who otherwise qualify under the FDA label are excluded from new weight-loss coverage
.png)
